Publication | Closed Access

Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial

Metabolic SyndromeBiochemical MarkersHepatologyLiver PhysiologyPharmacologyHepatology InflammationPlacebo-controlled TrialDelta-tocotrienol SupplementationHepatotoxicityLiver DiseaseFatty Liver DiseaseLiverMedicineHealth Sciences